This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
Diageo (DEO) Posts Strong 1H19 Earnings, Ups FY19 Sales View
by Zacks Equity Research
Diageo (DEO) reports strong top and bottom-line results for the first half of fiscal 2019, backed by solid organic growth. Further, the outlook for fiscal 2019 remains robust.
Colgate (CL) Q4 Earnings Beat, Soft 2019 View Hurts Stock
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2018 earnings and sales beat estimates on solid organic sales, and improved pricing. However, the company issues a soft earnings view for 2019.
Expansion & Innovation to Aid Diageo's (DEO) 1H19 Earnings
by Zacks Equity Research
Diageo (DEO) witnesses solid trends, backed by the focus on expanding geographic footprint and launching innovative products. This should continue to drive earnings in the quarters ahead.
Softness in Beer Hurt Alcohol Stocks, Can Cannabis Change Fate?
by Zacks Equity Research
The alcohol space continues its struggles against soft beer sales and higher costs. Meanwhile, cannabis-infused drinks are gaining popularity.
Alcohol Outlook: Soft Beer Demand & High Costs to Hurt
by Zacks Equity Research
The Beverages - Alcohol industry is in the doldrums due to softness in the beer segment, the consumers' shift to healthy options and higher aluminum costs, which is hurting investors' confidence.
Why Ambev (ABEV) Could Be Positioned for a Slump
by Zacks Equity Research
Ambev (ABEV) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Ambev S.A. (ABEV): Moving Average Crossover Alert
by Zacks Equity Research
Ambev S.A. (ABEV) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
AB InBev (BUD) Q1 Earnings Lag, Global Brands Aid Sales Beat
by Zacks Equity Research
AB InBev (BUD) reports lower-than-expected earnings per share in first-quarter 2018 while sales beat estimates. Sales gain from strong global brands and revenue management initiatives.
ABEV vs. BUD: Which Alcohol Stock is Better Before Earnings?
by Zacks Equity Research
With both brewers, Anheuser-Busch InBev SA/NV (BUD) and Ambev S.A. (ABEV) scheduled to report earnings on May 9, this may be a good time to consider which of these is a better stock.
FEMSA (FMX) Stock Rises Despite Q1 Earnings & Sales Miss
by Zacks Equity Research
FEMSA's (FMX) top and bottom lines lag estimates in first-quarter 2018. However, the top line improves year over year and margins rise across all segments.